arbekacin has been researched along with Osteomyelitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Itokazu, M; Kato, N; Ohno, T; Tanemori, T; Wada, E; Watanabe, K | 1 |
| Itokazu, M; Kumazawa, S; Matsunaga, T; Oka, M | 1 |
2 other study(ies) available for arbekacin and Osteomyelitis
| Article | Year |
|---|---|
Antibiotic-loaded hydroxyapatite blocks in the treatment of experimental osteomyelitis in rats.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Colony Count, Microbial; Dibekacin; Drug Delivery Systems; Drug Implants; Hydroxyapatites; Male; Osteomyelitis; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Tibia | 1997 |
Treatment of osteomyelitis by antibiotic impregnated porous hydroxyapatite block.
Topics: Adolescent; Alcaligenes; Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Delivery Systems; Durapatite; Female; Hip Prosthesis; Humans; Male; Middle Aged; Osteomyelitis; Prosthesis-Related Infections; Staphylococcal Infections; Staphylococcus epidermidis; Tuberculosis | 1994 |